ArticleTherapeutic advances in gastroenterology2016

Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France.

Anastasiia Kabeshova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.